Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icross vs Hyabak in Evaporative Dry Eye
NCT06517667Phase 3Completed
- Sponsor
- University of Seville
- Start
- Nov 2023
- Primary completion
- Feb 2024
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of I-Cross in dry eye syndrome (DED), sponsored by University of Seville. Started Nov 2023; status: completed.
02
Drugs
I-Cross
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06517667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06517667.